Massachussets General Hospital Cancer Center — Boston, Massachusetts

Massachussets General Hospital Cancer Center is a clinical research site located in Boston, Massachusetts, United States.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Massachussets General Hospital Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Brain and Central Nervous System Tumors.

Sponsors: European Organisation for Research and Treatment of Cancer - EORTC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachussets General Hospital Cancer Center?

Massachussets General Hospital Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachussets General Hospital Cancer Center conducted?

Massachussets General Hospital Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Brain and Central Nervous System Tumors.

Is Massachussets General Hospital Cancer Center accredited by Crixeo Health?

Massachussets General Hospital Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachussets General Hospital Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.